340B Informed

700-plus hospitals join 340B letter to Congress

Print Article October 3, 2018—Chief executives of more than 700 hospitals and health systems from all 50 states and the District of Columbia delivered a message today to the top Republican and Democratic leaders of Congress: Protect the 340B drug discount program from legislative or regulatory efforts to curtail its effectiveness. “Americans are right to […]

Hospital Groups Reiterate Opposition to CMS’s 340B Hospital Payment Cuts

Print ArticleSeptember 27, 2018—Major national hospital associations this week protested the federal government’s plan to continue a nearly 30 percent reduction in Medicare drug reimbursement to 340B hospitals in 2019 and extend the payment cuts to certain outpatient departments that are currently exempt. In separate public comments sent to the Centers for Medicare & Medicaid […]

Faces of 340B: Every Patient, Every Time

September 26, 2018—Madison Memorial Hospital is a 69-bed, county-owned facility in southeastern Idaho that provides needed primary and specialty care for its community without relying on any additional funding from the taxpayers. Part of how it can … [Read More...]

340B Health and Other Groups Sue HHS Challenging Delay of 340B Regulation

September 11, 2018—Today, 340B Health and three other national hospital associations have filed suit to force the U.S. Department of Health and Human Services (HHS) to enforce rules prohibiting manufacturers from overcharging 340B providers. The suit … [Read More...]

Writing in The New York Times, Economist Ignores Research Showing 340B Is Working

September 7, 2018—Healthcare economist Austin Frakt recently wrote in The New York Times that the 340B drug discount program includes hospitals “that don’t need the extra help” and don’t use the program to benefit low-income patients. That’s a … [Read More...]

Faces of 340B: Lifesaving Care During Disasters

August 23, 2018—Hurricane Harvey made landfall in Texas just over a year ago, dumping more than 40 inches of rain in the Houston metropolitan area. More than 30,000 people were displaced in the resulting floods. It also created a public health crisis … [Read More...]

New Independent Study Confirms 340B is a Small Share of U.S. Drug Market

August 8, 2018—A new report by independent researchers refutes claims by the pharmaceutical industry that the 340B drug pricing program is so large it forces manufacturers to raise their prices. Writing in the Health Affairs Blog, a team of … [Read More...]

New Study on Cancer Care Has Important Implications for 340B

August 7, 2018—Critics of the 340B drug pricing program often claim that the lower cost of drugs for 340B hospitals is driving up the cost of care for cancer patients in hospital outpatient departments. But a new study published in the American … [Read More...]

340binformed.org

Faces of 340B: “Healing for Life”